Osborne Clarke advises pioneering AI lung cancer diagnosis innovator Optellum on US$14m Series A funding round
International legal practice Osborne Clarke has advised Oxford-based MedTech company providing breakthrough AI platform to diagnose and treat early-stage lung...
Published on
07/10/2022
Read time
1m